Ligand Pharmaceuticals
LGND
$70.57
Share price
0.28%
Change (1 day)
-8.66%
Change (1 year)
Ligand Pharmaceuticals (LGND) - Cash on Hand
Cash on Hand as of December 2023 : $0.17 B
According to Ligand Pharmaceuticals's latest financial reports the company has $0.17 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Ligand Pharmaceuticals - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.17 B | -19.62% |
| 2022-12-31 | $0.21 B | -37.89% |
| 2021-12-31 | $0.34 B | -17.04% |
| 2020-12-31 | $0.41 B | -61.57% |
| 2019-12-31 | $1.06 B | 38.26% |
| 2018-12-31 | $0.77 B | 283.73% |
| 2017-12-31 | $0.20 B | 42.97% |
| 2016-12-31 | $0.14 B | -29.55% |
| 2015-12-31 | $0.20 B | 19.65% |
| 2014-12-31 | $0.16 B | 947.22% |
| 2013-12-31 | $15.97 M | 29.06% |
| 2012-12-31 | $12.38 M | -27.35% |
| 2011-12-31 | $17.04 M | -24.92% |
| 2010-12-31 | $22.69 M | -57.36% |
| 2009-12-31 | $53.23 M | -34.01% |
| 2008-12-31 | $80.67 M | -14.55% |
| 2007-12-31 | $94.4 M | -45.06% |
| 2006-12-31 | $0.17 B | 97.69% |
| 2005-12-31 | $86.93 M | -22.72% |
| 2004-12-31 | $0.11 B | 13.59% |
| 2003-12-31 | $99.03 M | 54.14% |
| 2002-12-31 | $64.24 M | 70.47% |
| 2001-12-31 | $37.68 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 13,362.00% | 🇺🇸 USA |
 Pfizer PFE | $12.69 B | 7,351.16% | 🇺🇸 USA |
 Eli Lilly LLY | $2.92 B | 1,619.05% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 6,325.97% | 🇺🇸 USA |
 Baxter BAX | $3.19 B | 1,775.41% | 🇺🇸 USA |
 Merck MRK | $7.09 B | 4,064.78% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $12.28 B | 7,110.42% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.35 B | 3,631.35% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | $56.13 M | -67.04% | 🇺🇸 USA |